Literature DB >> 27000065

Mitochondrial Pathology and Glycolytic Shift during Proximal Tubule Atrophy after Ischemic AKI.

Rongpei Lan1, Hui Geng1, Prajjal K Singha1, Pothana Saikumar1, Erwin P Bottinger2, Joel M Weinberg3, Manjeri A Venkatachalam4.   

Abstract

During recovery by regeneration after AKI, proximal tubule cells can fail to redifferentiate, undergo premature growth arrest, and become atrophic. The atrophic tubules display pathologically persistent signaling increases that trigger production of profibrotic peptides, proliferation of interstitial fibroblasts, and fibrosis. We studied proximal tubules after ischemia-reperfusion injury (IRI) to characterize possible mitochondrial pathologies and alterations of critical enzymes that govern energy metabolism. In rat kidneys, tubules undergoing atrophy late after IRI but not normally recovering tubules showed greatly reduced mitochondrial number, with rounded profiles, and large autophagolysosomes. Studies after IRI of kidneys in mice, done in parallel, showed large scale loss of the oxidant-sensitive mitochondrial protein Mpv17L. Renal expression of hypoxia markers also increased after IRI. During early and late reperfusion after IRI, kidneys exhibited increased lactate and pyruvate content and hexokinase activity, which are indicators of glycolysis. Furthermore, normally regenerating tubules as well as tubules undergoing atrophy exhibited increased glycolytic enzyme expression and inhibitory phosphorylation of pyruvate dehydrogenase. TGF-β antagonism prevented these effects. Our data show that the metabolic switch occurred early during regeneration after injury and was reversed during normal tubule recovery but persisted and became progressively more severe in tubule cells that failed to redifferentiate. In conclusion, irreversibility of the metabolic switch, taking place in the context of hypoxia, high TGF-β signaling and depletion of mitochondria characterizes the development of atrophy in proximal tubule cells and may contribute to the renal pathology after AKI.
Copyright © 2016 by the American Society of Nephrology.

Entities:  

Keywords:  ischemia-reperfusion; metabolism; mitochondria; pathology; proximal tubule

Mesh:

Year:  2016        PMID: 27000065      PMCID: PMC5084876          DOI: 10.1681/ASN.2015020177

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  64 in total

1.  Coexpression of keratin and vimentin in damaged and regenerating tubular epithelia of the kidney.

Authors:  H J Gröne; K Weber; E Gröne; U Helmchen; M Osborn
Journal:  Am J Pathol       Date:  1987-10       Impact factor: 4.307

Review 2.  Renal substrate metabolism.

Authors:  G Wirthensohn; W G Guder
Journal:  Physiol Rev       Date:  1986-04       Impact factor: 37.312

Review 3.  Hormonal regulation of hepatic gluconeogenesis.

Authors:  N Kraus-Friedmann
Journal:  Physiol Rev       Date:  1984-01       Impact factor: 37.312

Review 4.  Pathophysiology of acute kidney injury to chronic kidney disease: maladaptive repair.

Authors:  Li Yang; Benjamin D Humphreys; Joseph V Bonventre
Journal:  Contrib Nephrol       Date:  2011-09-09       Impact factor: 1.580

5.  Mitochondrial biogenesis in kidney disease.

Authors:  Joel M Weinberg
Journal:  J Am Soc Nephrol       Date:  2011-02-25       Impact factor: 10.121

6.  Differential effects of respiratory inhibitors on glycolysis in proximal tubules.

Authors:  K G Dickman; L J Mandel
Journal:  Am J Physiol       Date:  1990-06

7.  Transforming growth factor-beta receptor type 1 (TGFbetaRI) kinase activity but not p38 activation is required for TGFbetaRI-induced myofibroblast differentiation and profibrotic gene expression.

Authors:  Ann M Kapoun; Nicholas J Gaspar; Ying Wang; Debby Damm; Yu-Wang Liu; Gilbert O'young; Diana Quon; Andrew Lam; Kimberly Munson; Thomas-Toan Tran; Jing Ying Ma; Alison Murphy; Sundeep Dugar; Sarvajit Chakravarty; Andrew A Protter; Fu-Qiang Wen; Xiangde Liu; Stephen I Rennard; Linda Slanec Higgins
Journal:  Mol Pharmacol       Date:  2006-05-17       Impact factor: 4.436

8.  Transforming growth factor-beta in acute renal failure: receptor expression, effects on proliferation, cellularity, and vascularization after recovery from injury.

Authors:  Kimberly R Spurgeon; Deborah L Donohoe; David P Basile
Journal:  Am J Physiol Renal Physiol       Date:  2004-11-09

9.  HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia.

Authors:  Jung-whan Kim; Irina Tchernyshyov; Gregg L Semenza; Chi V Dang
Journal:  Cell Metab       Date:  2006-03       Impact factor: 27.287

10.  Severe renal mass reduction impairs recovery and promotes fibrosis after AKI.

Authors:  Aaron J Polichnowski; Rongpei Lan; Hui Geng; Karen A Griffin; Manjeri A Venkatachalam; Anil K Bidani
Journal:  J Am Soc Nephrol       Date:  2014-02-07       Impact factor: 10.121

View more
  106 in total

Review 1.  Pharmacologic Approaches to Improve Mitochondrial Function in AKI and CKD.

Authors:  Hazel H Szeto
Journal:  J Am Soc Nephrol       Date:  2017-08-04       Impact factor: 10.121

2.  Glycolysis inhibitors suppress renal interstitial fibrosis via divergent effects on fibroblasts and tubular cells.

Authors:  Qingqing Wei; Jennifer Su; Guie Dong; Ming Zhang; Yuqing Huo; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2019-04-10

3.  Metabolic reprogramming by N-acetyl-seryl-aspartyl-lysyl-proline protects against diabetic kidney disease.

Authors:  Swayam Prakash Srivastava; Julie E Goodwin; Keizo Kanasaki; Daisuke Koya
Journal:  Br J Pharmacol       Date:  2020-06-22       Impact factor: 8.739

4.  Interleukin-1β Activates a MYC-Dependent Metabolic Switch in Kidney Stromal Cells Necessary for Progressive Tubulointerstitial Fibrosis.

Authors:  Dario R Lemos; Michael McMurdo; Gamze Karaca; Julia Wilflingseder; Irina A Leaf; Navin Gupta; Tomoya Miyoshi; Koichiro Susa; Bryce G Johnson; Kirolous Soliman; Guanghai Wang; Ryuji Morizane; Joseph V Bonventre; Jeremy S Duffield
Journal:  J Am Soc Nephrol       Date:  2018-05-08       Impact factor: 10.121

5.  Hyperpolarized 13 C magnetic resonance evaluation of renal ischemia reperfusion injury in a murine model.

Authors:  Celine Baligand; Hecong Qin; Aisha True-Yasaki; Jeremy W Gordon; Cornelius von Morze; Justin Delos Santos; David M Wilson; Robert Raffai; Patrick M Cowley; Anthony J Baker; John Kurhanewicz; David H Lovett; Zhen Jane Wang
Journal:  NMR Biomed       Date:  2017-07-14       Impact factor: 4.044

6.  A Case of Drug-Induced Proximal Tubular Dysfunction.

Authors:  Andrew M Hall; Robert J Unwin
Journal:  Clin J Am Soc Nephrol       Date:  2019-06-10       Impact factor: 8.237

7.  Preventing the Progression of AKI to CKD: The Role of Mitochondria.

Authors:  Sophie de Seigneux; Pierre-Yves Martin
Journal:  J Am Soc Nephrol       Date:  2017-03-23       Impact factor: 10.121

8.  Inhibition of 5-lipoxygenase decreases renal fibrosis and progression of chronic kidney disease.

Authors:  John R Montford; Colin Bauer; Evgenia Dobrinskikh; Katharina Hopp; Moshe Levi; Mary Weiser-Evans; Raphael Nemenoff; Seth B Furgeson
Journal:  Am J Physiol Renal Physiol       Date:  2019-01-16

9.  The Emerging Role of Mitophagy in Kidney Diseases.

Authors:  Divya Bhatia; Mary E Choi
Journal:  J Life Sci (Westlake Village)       Date:  2019-12

Review 10.  The role of metabolic reprogramming in tubular epithelial cells during the progression of acute kidney injury.

Authors:  Zhenzhen Li; Shan Lu; Xiaobing Li
Journal:  Cell Mol Life Sci       Date:  2021-06-29       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.